Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid

Experimental Neurology

Volumn 172, Issue 1, 2001, Pages 172-181

  Massioui, Nicole El ^a   Ouary, Stéphane ^b   Chéruel, Fabrice ^a   Hantraye, Philippe ^b   Brouillet, Emmanuel ^b  

^a INSTITUT D'OPTIQUE GRADUATE SCHOOL   (France)

^b CNRS   (France)

Author keywords

3 nitropropionic acid; Basal ganglia degeneration; Huntington's disease; Perseveration; Set shifting deficit

Indexed keywords

3 NITROPROPIONIC ACID; NEUROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; BASAL GANGLION; BRADYKINESIA; CELL LOSS; COGNITIVE DEFECT; DYSTONIA; ENTOPEDUNCULAR NUCLEUS; GAIT DISORDER; HUNTINGTON CHOREA; LEARNING DISORDER; MAZE TEST; MOTOR DYSFUNCTION; NERVE DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

EID: 0035211142     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7766     Document Type: Article

References (60)

1. Microstimulation of the primate neostriatum. II. Somatotopic organization of striatal microexcitable zones and their relation to neuronal response properties
2. Metabolic compromise with 3-nitropropionic acid produced striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice
3. A prospective evaluation of cognitive decline in early Huntington's disease: Functional and radiographic correlates
4. Neurochemical and histologic characterization of the striatal lesions produced by the mitochondrial toxins 3-nitropropionic acid
5. Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease
6. Cognitive impairments in Huntington's disease: Insights into the neuropsychology of the striatum
7. The dementia of Huntington's disease
8. Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates
9. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat
10. Replicating Huntington's disease in experimental animals
11. Huntington's chorea: Current neuropathological status
12. Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum
13. Representation of the body by single neurons in the dorsolateral striatum of the awake, unrestrained rat
14. Characterisation of progressive motor deficits in mice transgenic for the human Huntington's disease mutation
15. Frontal-subcortical circuits and human behavior
16. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid
17. Dissociation of hippocampal and striatal contributions to spatial navigation in the water maze
18. Neurotoxic lesions of ventrolateral but not anteromedial neostriatum in rats impair differential reinforcement of low rates (DRL) performance
19. Effects of regional striatal lesions on motor, motivational, and executive aspects of progressive-ratio performance in rats
20. Frontal lobe and frontal-striatal substrates for different forms of human cognitive flexibility
21. Neuropsychological profile of Huntington's disease: Patients and those at risk
22. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid
23. Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats
24. Differential effects of lesions of the dorsomedial and dorsolateral caudate-putamen on reaction time performance in rats
25. Development of neuropsychological deficits in Huntington's disease
26. Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid
27. Caudate nucleus lesions and perseverative behavior
28. New insights into the clinical features, pathogenesis and molecular genetics of Huntington's disease
29. Morphometric studies of the neuropathological changes in choreatic diseases
30. Executive and mnemonic functions in early Huntington's disease
31. Evidence for specific cognitive deficits in pre-clinical Huntington's disease
32. Discrimination, reversal, and shift-learning in Huntington's disease: Mechanisms of impaired response selection
33. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation
34. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease
35. Parallel information processing in the water maze: Evidence for independent memory systems involving dorsal striatum and hippocampus
36. Cortical, hippocampal, and striatal mediation of schedule-induced behaviors
37. Strategies used by hippocampal and caudate- putamen-lesioned rats in learning task
38. Comparative neuropsychology and Korsakoff's syndrome. III. Delayed responses, delayed alternation and DRL performance
39. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionate in rats: Implications for neuroprotection studies
40. Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease
41. Differential effects of fornix and caudate nucleus lesions on two radial maze tasks: Evidence for multiple memory systems
42. Double dissociation of fornix and caudate nucleus lesions on acquisition of two water maze tasks: Further evidence for multiple memory systems
43. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: Acute excitotoxic necrosis and delayed apoptosis
44. Explicit memory in Alzheimer's, Parkinson's and Huntington's diseases
45. Are explicit memory disorders of progressive supranuclear palsis related to damage to striatofrontal circuits? Comparisons with Alzheimer's, Parkinson's and Huntington's diseases
46. Regionally selective roles of the rat's striatum in modality-specific discrimination and forelimb reaching
47. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models
48. Dissociable roles of the ventral, medial and lateral striatum on the acquisition and performance of a complex visual stimulus-response habit
49. The basal ganglia: A vertebrate solution to the selection problem?
50. Perseverations during paired-associate learning in Huntington's disease
51. Behavior and the basal ganglia
52. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo
53. Associative learning in degenerative neostriatal disorders: Contrasts in explicit and implicit remembering between Parkinson's and Huntington's diseases
54. An investigation of unilateral cerebral pathology with equated verbal and visual-spatial tasks
55. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease
56. Rule based learning impairment in rats with lesions to the dorsalstriatum
57. Neuropathological classification of Huntington's disease
58. A histometrical study on the globus pallidus in Huntington's disease